drugset / Trial / NCT03777930

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

NCT03777930

Phase 4 Unknown 200 enrolled Shenzhen Fifth People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

To observe the effect of thalidomide combined with megestrol acetate on lymphocyte, inflammatory factor regulation and nutritional status in patients with advanced malignant tumors.

Timeline

Start
2018-12-10
Primary completion
2020-10-10
Completion
2021-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified 0.16 unknown Oral
Subject Thalidomide Other / unclassified 100 mg Oral